Shares of International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH) could be a deep value opportunity at this point with a string of strong catalysts already in play. All it would take is a spark. The latest announcement is potentially that spark, so we wanted to take a look at it a bit closer. Specifically, the company just announced the full execution by all parties of a partnership agreement with BioPulse Labs, a leader in cutting-edge CBD nano-infusion formulation technology and CBD-based product brand development.
According to the release, the Agreement appoints BioPulse as ISWH’s exclusive manufacturing and marketing partner for the launch of five (5) CBD-based wellness products, which will include a comprehensive branding refresh for the Company’s P19 CBD-based products brand, with all CBD-based products formulated and produced in FDA compliant and registered facilities.
International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH) bills itself as a diversified brand incubator with operations in two primary divisions, together spanning the Spirits, Home Healthcare Services, and CBD-Based Products markets worldwide.
The Spirits Division imports, licenses, and markets premium beverage brands, with sales of innovative products and brands, including its award-winning premium Besado Tequila brand.
The Company’s Home Healthcare Services segment provides care for clients in need of healthcare and caretaking services outside of established medical facilities. The Company continues to increase both its fleet of caretakers providing services and its total clientele.
The CBD-Based Products segment is focused on reshaping the CBD products market through state-of-the-art nanotechnology processes, developing a wide range of nano-infused CBD gummies and beverages formulations for sale under the “P19” brand designation. This line of products is formulated and marketed in partnership with BioPulse Labs, a leader in cutting-edge CBD nano-infusion formulation technology and CBD-based product brand development.
The company has also partnered with Bengala Technologies in the development and commercialization of enterprise and B2B software technology products targeting the logistics and supply-chain marketplace.
Find out when $ISWH reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, ISWH just announced the full execution by all parties of a partnership agreement with BioPulse Labs, a leader in cutting-edge CBD nano-infusion formulation technology and CBD-based product brand development.
This catalyst could help to spark some fresh enthusiasm and kickstart the stock off its deep sub-penny share pricing. Our sense is that it could be worth watching if momentum starts to develop at this point given how far the company appears to have come in terms of a turnaround under the surface of the tape.
Terry Williams, CEO of ISWH, commented, “BioPulse has the experience and capability to step in and help take our CBD-based products segment to a new level as we navigate this critical stage and transform enormous potential into accelerating revenue growth. This step will position our P19 brand as a differentiated product, both in terms of product quality through superior bioavailability and in terms of brand recognition, given BioPulse’s nationwide marketing and distribution footprint.”
Earning a current market cap value of $375K, ISWH is pulling in trailing 12-month revenues of $353K. In addition, the company is seeing recent top-line growth, with sequential quarterly revenues growing at 28%. As more color becomes clear on the name, we will review the situation and update our take. Sign-up for continuing coverage on shares of $ISWH stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $ISWH, either long or short, and we have not been compensated for this article.